Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036

globenewswire.com
SNY Sanofi is mentioned as a key player in the asthma market, which is projected to grow. The article does not provide specific details on Sanofi's performance or outlook within this market. REGN Regeneron Pharmaceuticals is listed as a key player in the growing asthma market. The article does not offer specific insights into Regeneron's individual performance or future prospects. AMGN Amgen is identified as a key participant in the asthma market, which is expected to expand. The article lacks specific details regarding Amgen's role or outlook within this sector. AZN AstraZeneca is named as a key player in the asthma market, which is forecasted to grow. The article does not provide specific information about AstraZeneca's performance or future in this market. GSK GlaxoSmithKline is mentioned as a key player in the asthma market, which is projected to experience growth. The article does not offer specific details on GSK's performance or outlook. NVS Novartis is listed as a key player in the asthma market, which is expected to grow. The article does not provide specific insights into Novartis's individual performance or future prospects. TEVA Teva Pharmaceuticals is identified as a key participant in the asthma market, which is forecasted to expand. The article lacks specific details regarding Teva's role or outlook within this sector.

7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036 Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Asthma - Market Insight, Epidemiology, and Market Forecast - 2036" has been added to ResearchAndMarkets.com's offering.

The asthma market in the 7MM is expected to grow from an estimated USD 27 billion in 2024 at a CAGR of 1.9% from 2026 to 2036. Key players include Sanofi, Regeneron Pharmaceuticals, Amgen, AstraZeneca, Areteia Therapeutics, GlaxoSmithKline, Chiesi Farmaceutici, Novartis, and Teva Pharmaceuticals.

Asthma Market and Epidemiology Analysis

Key Factors Driving the Asthma Market

The market report explores current treatment practices, emerging drugs, and forecasts the asthma market size from 2022 to 2036, including treatment strategies and unaddressed medical needs.

Asthma Disease Understanding

Asthma is marked by airway inflammation that leads to obstructive airflow, often exacerbated by environmental triggers. Severe asthma encompasses Type 2 and non-Type 2 categories, each responding differently to treatment, making personalized therapy essential.

Asthma Diagnosis and Treatment

Diagnosis is confirmed through symptom assessment and spirometry. Treatment varies per severity, commonly starting with inhaled corticosteroids and progressing with biologics for more severe cases.

Asthma Epidemiology

Asthma Recent Developments

Asthma Drug Analysis DUPIXENT (dupilumab)

A biologic targeting IL-4 and IL-13 for controlling moderate-to-severe asthma.

TEZSPIRE (tezepelumab)

Targets TSLP to manage airway inflammation across various types of severe asthma.

FASENRA (benralizumab)

Depletes eosinophils, offering long-term control for severe eosinophilic asthma.

Asthma Market Outlook

Asthma Competitive Landscape

The competitive landscape is diverse, with companies enhancing drug delivery systems and launching novel biologics, while generics increase pricing competition.

Asthma Market Access and Reimbursement

The report also provides critical insights on country-specific accessibility, reimbursement scenarios, patient assistance programs, and market access dynamics.

Reasons to Buy Asthma Market Forecast Report

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/nhx23k

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.